LEN Stock Analysis: Lennar | NYSE
Residential Construction | NYSE, USA | Market Cap: 20.972m USD | 12M Return: -18.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 269M
EPS Trend: -87.4%
Qual. Beats: 0
Rev. Trend: -34.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Lennar Corporation (NYSE: LEN) is a Miami, Florida-based homebuilder founded in 1954 and listed as a large-cap stock in the Consumer Discretionary sector under the GICS Homebuilding sub-industry. The company is one of the largest residential construction firms in the United States, operating primarily under the Lennar brand through four geographic homebuilding segments covering the East, Central, South Central, and West regions.
Beyond single-family attached and detached home construction, Lennar is involved in residential land acquisition and development, multifamily rental property development and management, and fund investment activities. It also operates a Financial Services segment that offers mortgage financing, title insurance, and closing services, as well as the origination and sale of securitized commercial mortgage loans.
The company targets first-time, move-up, active adult, and luxury homebuyers. Large publicly traded U.S. homebuilders like Lennar commonly operate captive mortgage businesses alongside their homebuilding operations, which helps streamline the purchase process for buyers and provides a recurring revenue stream tied to housing transactions. As a consumer discretionary industry, homebuilding is historically cyclical and sensitive to mortgage interest rates, housing affordability, and broader economic conditions.
- Mortgage rate cuts drive new home order growth
- Lumber and labor costs squeeze homebuilding gross margins
- Capital returns accelerate via buybacks and dividends
| Net Income: 1.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.32 > 1.0 |
| NWC/Revenue: 43.97% < 20% (prev 35.98%; Δ 7.99% < -1%) |
| CFO/TA 0.03 > 3% & CFO 883.0m > Net Income 1.62b |
| Net Debt (4.38b) to EBITDA (2.11b): 2.08 < 3 |
| Current Ratio: 4.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (242.6m) vs 12m ago -7.23% < -2% |
| Gross Margin: 7.95% > 18% (prev 13.27%; Δ -5.32% > 0.5%) |
| Asset Turnover: 96.18% > 50% (prev 102.9%; Δ -6.72% > 0%) |
| Interest Coverage Ratio: 8.20 > 6 (EBIT TTM 1.97b / Interest Expense TTM 240.3m) |
| A: 0.43 (Total Current Assets 18.3b - Total Current Liabilities 3.94b) / Total Assets 33.7b |
| B: 0.68 (Retained Earnings 22.8b / Total Assets 33.7b) |
| C: 0.06 (EBIT TTM 1.97b / Avg Total Assets 34.0b) |
| D: 1.81 (Book Value of Equity 21.6b / Total Liabilities 11.9b) |
| Altman-Z'' = 7.29 = AAA |
| DSRI: 0.72 (Receivables 978.8m/1.47b, Revenue 32.7b/35.4b) |
| GMI: 1.67 (GM 13.27% / 7.95%) |
| AQI: 0.51 (AQ_t 0.25 / AQ_t-1 0.48) |
| SGI: 0.93 (Revenue 32.7b / 35.4b) |
| TATA: 0.02 (NI 1.62b - CFO 883.0m) / TA 33.7b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of July 06, 2026, the stock is trading at USD 88.21 with a total of 2,293,524 shares traded. Over the past week, the price has changed by -6.02%, over one month by -2.52%, over three months by +0.12% and over the past year by -18.10%.
Current recommended Stop Loss: 82.20 (which is 6.8% or 1.8 ATR below the current price).
Lennar has received a consensus analysts rating of 3.48. Therefore, it is recommended to hold LEN.
- StrongBuy: 4
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 88.5 | 0.4% |
P/E Trailing = 13.6458
P/E Forward = 16.0256
P/S = 0.6406
P/B = 1.0082
P/EG = 12.3199
Revenue TTM = 32.7b USD
EBIT TTM = 1.97b USD
EBITDA TTM = 2.11b USD
Long Term Debt = 6.01b USD (from longTermDebt, last quarter)
Short Term Debt = 2.15b USD (from shortTermDebt, last quarter)
Debt = 6.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.38b USD (calculated: Debt 6.20b - CCE 1.82b)
Enterprise Value = 25.4b USD (21.0b + Debt 6.20b - CCE 1.82b)
Interest Coverage Ratio = 8.20 (Ebit TTM 1.97b / Interest Expense TTM 240.3m)
EV/FCF = 35.37x (Enterprise Value 25.4b / FCF TTM 716.8m)
FCF Yield = 2.83% (FCF TTM 716.8m / Enterprise Value 25.4b)
FCF Margin = 2.19% (FCF TTM 716.8m / Revenue TTM 32.7b)
Net Margin = 4.94% (Net Income TTM 1.62b / Revenue TTM 32.7b)
Gross Margin = 7.95% ((Revenue TTM 32.7b - Cost of Revenue TTM 30.1b) / Revenue TTM)
Gross Margin QoQ = 6.18% (prev 5.90%)
Tobins Q-Ratio = 0.75 (Enterprise Value 25.4b / Total Assets 33.7b)
Interest Expense / Debt = 3.88% (Interest Expense 240.3m / Debt 6.20b)
Taxrate = 25.13% (550.1m / 2.19b)
NOPAT = 1.47b (EBIT 1.97b * (1 - 25.13%))
Current Ratio = 4.66 (Total Current Assets 18.3b / Total Current Liabilities 3.94b)
Debt / Equity = 0.29 (Debt 6.20b / totalStockholderEquity, last quarter 21.6b)
Debt / EBITDA = 2.08 (Net Debt 4.38b / EBITDA 2.11b)
Debt / FCF = 6.11 (Net Debt 4.38b / FCF TTM 716.8m)
Total Stockholder Equity = 22.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.76% (Net Income 1.62b / Total Assets 33.7b)
RoE = 7.36% (Net Income TTM 1.62b / Total Stockholder Equity 22.0b)
RoCE = 7.03% (EBIT 1.97b / Capital Employed (Equity 22.0b + L.T.Debt 6.01b))
RoIC = 4.87% (NOPAT 1.47b / Invested Capital 30.3b)
WACC = 7.35% (E(21.0b)/V(27.2b) * Re(8.66%) + D(6.20b)/V(27.2b) * Rd(3.88%) * (1-Tc(0.25)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -5.71%
[DCF] Terminal Value 77.97% ; FCFF base≈541.5m ; Y1≈620.8m ; Y5≈913.6m
[DCF] Fair Price = 44.49 (EV 13.7b - Net Debt 4.38b = Equity 9.37b / Shares 210.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -87.40 | EPS CAGR: -26.60% | SUE: 0.35 | # QB: 0
Revenue Correlation: -34.44 | Revenue CAGR: -1.27% | SUE: -0.61 | # QB: 0
EPS current Quarter (2026-08-31): EPS=1.72 | Chg30d=-1.31% | Revisions=-25% | Analysts=11
EPS current Year (2026-11-30): EPS=5.57 | Chg30d=-6.78% | Revisions=-25% | GrowthEPS=-30.9% | GrowthRev=-4.7%
EPS next Year (2027-11-30): EPS=6.60 | Chg30d=-12.76% | Revisions=-25% | GrowthEPS=+18.5% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -50% (up=0, down=3)